So Min Park

Title: So Min Park: Innovator in Dioxoloisoquinolinone Derivatives

Introduction

So Min Park is a talented inventor based in Hwaseong-si, South Korea. He is known for his significant contributions in the field of pharmaceutical chemistry, particularly through his innovative work on dioxoloisoquinolinone derivatives.

Latest Patents

So Min Park holds one notable patent titled "Dioxoloisoquinolinone derivatives and use thereof." This patent discloses novel dioxoisoquinolinone derivative compounds, including pharmaceutically acceptable salts, optical isomers, hydrates, and solvates. These compounds have shown promising inhibition activity against EZH1 (Enhancer of zeste homolog 1) and EZH2 (Enhancer of zeste homolog 2). Additionally, the patent outlines the potential for pharmaceutical compositions developed from these compounds, offering new possibilities in medical treatments.

Career Highlights

So Min Park works at Hanmi Pharmaceutical Co., Ltd., a company known for its commitment to advancing pharmaceutical research and offerings. His role at the company allows him to leverage his innovative skills to contribute to the development of new therapeutic solutions, further enhancing the company's position in the pharmaceutical industry.

Collaborations

Throughout his career, So Min Park has collaborated with talented colleagues such as Seung Hyun Jung and Dong Jin Hong. These collaborations have been pivotal in the research and development of new compounds, contributing to the success of their collective efforts in the field.

Conclusion

With his groundbreaking work on dioxoloisoquinolinone derivatives, So Min Park exemplifies the spirit of innovation in the pharmaceutical industry. His contributions not only highlight his own ingenuity but also emphasize the importance of collaboration and research in developing effective medical therapies. As he continues his work at Hanmi Pharmaceutical Co., Ltd., the future looks promising for both his career and the advancements he is helping to bring to life.